TekniPlex Healthcare has initiated production at its newly established 200,000ft² facility in Madison, Wisconsin.
Located at 6002 Femrite Drive, this site is expected to enhance the company’s Barrier Protection Systems business.
According to the company, the new location seeks to merge manufacturing technologies with expertise in materials science.
This strategy aims to broaden capabilities and improve access to protective solutions throughout North America and internationally.
This facility will help boost TekniPlex Healthcare’s support for medical device and pharmaceutical firms.
It is designed to ensure “reliable” access to sterile barrier packaging for hospitals, outpatient surgical centres, laboratories, and patients, stated the company.
The Madison plant has received ISO 13485:2016 quality management system certification.
As TekniPlex Healthcare’s second site in Madison, it will concentrate on creating coated and printed solutions.
These products are crucial for safeguarding medical devices and wound care products from contaminants, ultimately enhancing patient outcomes.
The new plant is equipped with modern manufacturing infrastructure, including an air knife coater, added the company.
This machinery will help the company boost the supply of coated Tyvek and heat-seal coated reinforced papers for various sterilisation barrier applications.
Furthermore, the facility features a wide-width eight-colour high-definition flexographic printing press.
This technology enables TekniPlex Healthcare to fulfil stringent healthcare printing requirements while maintaining a near-zero waste manufacturing process.
Sustainability is a primary focus for the new facility, which has adopted an eco-friendly design approach.
The company states that at least 95% of the waste produced by the facility is recyclable.
Looking forward, the facility has plans for future expansion opportunities. These include the addition of a second flexographic printer, a cantilevered slitter rewinder, and a reversible salvage rewinder.
TekniPlex Healthcare CEO Suj Mehta said: “Our new flagship facility exemplifies TekniPlex Healthcare’s mission of improving patient care through solutions that protect, preserve, and perform. The products manufactured here directly impact patients’ lives.
“As a dedicated hub, the site not only expands our capacity and provides customers with supply chain assurances, but also serves as a knowledge base to build upon and maximise our leadership in barrier protection materials science.”
In October 2024, TekniPlex Healthcare introduced its new bio-based medical-grade polyvinyl chloride compounds.
